As an HIV-positive gay activist from Pakistan, my participation in the International AIDS Society (IAS) Regional Members’ Meeting is more than just a personal commitment. It represents the collective voice of marginalized communities striving for better healthcare and inclusivity. Being a proud member of the IAS since 2019, I have been actively engaged in its activities, ensuring that the concerns of people living with HIV, especially those from my region, are heard and addressed.
Scheduled to be held virtually on 31 October 2024, the IAS Regional Members’ Meeting will gather members from Asia and the Pacific Islands. With time slots tailored for different regions (13:00 in Mumbai, 14:30 in Bangkok, 16:30 in Tokyo, and 18:30 in Sydney), this meeting aims to foster inclusive dialogue and collaboration among IAS members.
- Introduction by Governing Council Members
The meeting was kicked off with an introduction by the Governing Council members, setting the stage for the discussions ahead. This session highlighted the strategic direction of the IAS and provide insights into the organization’s ongoing initiatives. It’s was opportunity for members like myself to understand the broader vision and align our efforts towards common goals. - Lenacapavir: Recent Results in HIV Prevention
One of the key topics on the agenda is the recent results in HIV prevention with Lenacapavir. This groundbreaking drug has shown promising results in clinical trials, offering hope for more effective prevention strategies. As someone living with HIV, the advancements in such treatments are personally significant and represent a beacon of hope for many in my community. - Availability and Accessibility of Lenacapavir in the Asia-Pacific
The discussion had also focused on the availability and accessibility of Lenacapavir in the Asia-Pacific region, including aspects of voluntary licensing. Ensuring that such innovative treatments are accessible to those who need them most is crucial. This segment had delve into the challenges and opportunities in making Lenacapavir widely available, addressing regulatory, logistical, and financial hurdles. The Harm Reduction Initiative shared the GiLeads efforts mentining that Gilead will deliver LEN swiftly, sustainably and in sufficient volumes. Establishing a robust voluntary licensing program with Dr. Reddy’s Laboratories Limited, Emcure, Eva Pharma, Ferozsons Laboratories Limited, Hetero and Mylan, a subsidiary of Viatris to manufacture and supply lenacapavir to the 120 countries. Prioritizing registration in 18 countries that represent about 70% of the HIV burden and provide Gilead-supplied product at no profit to Gilead until generic manufacturers are able to fully support demand. Working on additional ways to support access in upper-middle and high-income countries to establish fast, efficient pathways to help reach people who need or want PrEP, including timely regulatory filings, engagement with partners. - Hearing from IAS Members
The most anticipated part of the meeting is hearing from IAS members. This session was designed to provide a platform for members to share their experiences, challenges, and successes. As an advocate for the rights of HIV-positive individuals in Pakistan, I have contributed by sharing my insights and learning. This exchange of ideas is vital for fostering a supportive and informed community that can drive impactful change.
Participating in the IAS Regional Members’ Meeting is a testament to my commitment to HIV advocacy and community leadership. Through this engagement, I aim to amplify the voices of marginalized communities and contribute to the global fight against HIV. By addressing critical issues such as treatment accessibility and sharing best practices, we can work towards a future where everyone has the opportunity to lead a healthy and dignified life.
The IAS provides a unique platform for professionals like myself to collaborate, learn, and advocate for change. Together, we can ensure that our collective efforts translate into meaningful progress for the HIV community worldwide.
By being an active participant in such discussions, I am not only representing my personal journey but also the aspirations of countless individuals facing similar challenges. Our united voice can make a difference in shaping a more inclusive and equitable healthcare landscape.
Read more on International Aids Society members website Here
